Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Dare Bioscience (DARE) EBT (2021 - 2025)

Historic EBT for Dare Bioscience (DARE) over the last 5 years, with Q3 2025 value amounting to -$3.7 million.

  • Dare Bioscience's EBT rose 2155.79% to -$3.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$17.4 million, marking a year-over-year increase of 2530.02%. This contributed to the annual value of -$23.5 million for FY2024, which is 2420.31% up from last year.
  • As of Q3 2025, Dare Bioscience's EBT stood at -$3.7 million, which was up 2155.79% from -$3.8 million recorded in Q2 2025.
  • Dare Bioscience's 5-year EBT high stood at $384322.0 for Q2 2022, and its period low was -$16.2 million during Q4 2022.
  • Its 5-year average for EBT is -$7.1 million, with a median of -$7.1 million in 2022.
  • Per our database at Business Quant, Dare Bioscience's EBT skyrocketed by 10419.43% in 2022 and then plummeted by 243901.68% in 2023.
  • Over the past 5 years, Dare Bioscience's EBT (Quarter) stood at -$9.5 million in 2021, then plummeted by 70.08% to -$16.2 million in 2022, then soared by 68.14% to -$5.2 million in 2023, then dropped by 4.19% to -$5.4 million in 2024, then surged by 31.85% to -$3.7 million in 2025.
  • Its EBT stands at -$3.7 million for Q3 2025, versus -$3.8 million for Q2 2025 and -$4.6 million for Q1 2025.